Last10K.com

Cytosorbents Corp (CTSO) SEC Filing 8-K Material Event for the period ending Wednesday, December 13, 2023

Cytosorbents Corp

HISTORY TOOLS
CIK: 1175151 Ticker: CTSO

View differences made from one to another to evaluate Cytosorbents Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Cytosorbents Corp.

Continue

Assess how Cytosorbents Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Cytosorbents Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Cover

Material Contracts, Statements, Certifications & more

Cytosorbents Corp provided additional information to their SEC Filing as exhibits

Exhibit 5.1: Opinion Regarding Legality
Exhibit 99.1: Additional Exhibits
Ticker: CTSO
CIK: 1175151
Form Type: 8-K Corporate News
Accession Number: 0001104659-23-125598
Submitted to the SEC: Wed Dec 13 2023 9:15:22 AM EST
Accepted by the SEC: Wed Dec 13 2023
Period: Wednesday, December 13, 2023
Industry: Surgical And Medical Instruments And Apparatus
Events:
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/ctso/0001104659-23-125598.htm